신경계 원료의약품(API) 시장 보고서(2026년)

Nervous system active pharmaceutical ingredients are pharmacologically active compounds formulated to act on the central and peripheral nervous systems to diagnose, treat, prevent, or manage neurological and psychiatric disorders. These ingredients are intended for incorporation into finished dosage forms such as tablets, capsules, injectables, and liquid medicines used for treating nervous system-related conditions.

The key products of nervous system active pharmaceutical ingredients include cytokines, vaccines, fusion proteins, and therapeutic enzymes. Cytokines are protein-based molecules that regulate immune responses and are used to treat various neurological conditions. These products are produced using different expression systems, such as mammalian cells and microbial yeast. They are applied across multiple therapeutic areas, including diabetes, cardiovascular diseases, oncology, and neurological disorders, and are utilized by end users such as pharmaceutical companies, biopharmaceutical firms, contract development and manufacturing organizations, research and development laboratories, and generic drug manufacturers.

Tariffs on pharmaceutical intermediates, specialty chemicals, and bulk drug substances are impacting the nervous system active pharmaceutical ingredients market by increasing input and production costs. Synthetic and high potency api segments that rely on imported intermediates are most affected. Regions dependent on cross border chemical supply chains, especially in asia and north america, face higher manufacturing expenses. These cost pressures can tighten margins for generic api producers. At the same time, tariffs are encouraging domestic api manufacturing expansion and backward integration into raw material production.

The nervous system active pharmaceutical ingredients market research report is one of a series of new reports from The Business Research Company that provides nervous system active pharmaceutical ingredients market statistics, including nervous system active pharmaceutical ingredients industry global market size, regional shares, competitors with a nervous system active pharmaceutical ingredients market share, detailed nervous system active pharmaceutical ingredients market segments, market trends and opportunities, and any further data you may need to thrive in the nervous system active pharmaceutical ingredients industry. This nervous system active pharmaceutical ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nervous system active pharmaceutical ingredients market size has grown strongly in recent years. It will grow from $254.73 billion in 2025 to $268.45 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising neurological disorder prevalence, expansion of psychiatric drug use, growth of generic api manufacturing, increased cns drug approvals, expansion of contract api production.

The nervous system active pharmaceutical ingredients market size is expected to see strong growth in the next few years. It will grow to $334.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growth in neurodegenerative disease burden, expansion of specialty cns therapies, rising demand for high purity apis, increase in outsourced api manufacturing, growth of biologic neuro drugs. Major trends in the forecast period include high potency neurology api development, complex cns molecule synthesis, peptide based neuro apis, controlled release neuro api formats, specialized neuro api cdmo partnerships.

The rising prevalence of neurological disorders is anticipated to drive the growth of the nervous system active pharmaceutical ingredients market in the coming years. Neurological disorders refer to a wide range of medical conditions that impair the normal functioning of the central and peripheral nervous system, often resulting in symptoms such as seizures, paralysis, memory loss, or coordination difficulties. The prevalence of neurological disorders is increasing mainly due to the aging global population, as older individuals are more susceptible to neurodegenerative conditions such as Alzheimer's and Parkinson's disease because nerve cells naturally decline and become more vulnerable over time. Nervous system active pharmaceutical ingredients support neurological disorders by modulating neural signaling and protecting nerve cells, thereby slowing disease progression and improving symptom management in conditions such as epilepsy, multiple sclerosis, and neurodegenerative diseases. For example, in December 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, approximately 425,000 Australians were living with dementia in 2024, and this number is projected to increase 2.5 times, reaching over 1.1 million by 2065, including roughly 662,000 women and 390,000 men. Therefore, the rising prevalence of neurological disorders is driving the growth of the nervous system active pharmaceutical ingredients market.

Companies operating in the nervous system active pharmaceutical ingredients market are focusing on developing innovative solutions, such as cannabinoid-based active pharmaceutical ingredients, to enhance the efficacy, safety, and targeted delivery of treatments for neurological disorders. Cannabinoid-based active pharmaceutical ingredients (APIs) are highly purified natural or synthetic compounds that deliver therapeutic effects by targeting the body's endocannabinoid system to manage pain, epilepsy, nausea, and various neurological conditions. For example, in March 2024, Brains Bioceutical Corp., a Canada-based pharmaceutical company, launched solid D9 Tetrahydrocannabinol (THC), a cannabinoid-based active pharmaceutical ingredient designed to advance pharmaceutical research and drug development in neurological and pain management applications. This solid D9-THC API features a crystalline structure that improves storage stability and dosing accuracy over traditional cannabinoid extracts, facilitating its use in research and formulation development across therapeutic areas where CNS-active agents are critical. The product's development underscores the shift toward more sophisticated API formats that can support precise, scalable pharmaceutical manufacturing.

In January 2025, Johnson & Johnson, a US-based healthcare technology and pharmaceutical company, acquired Intra-Cellular Therapies Inc. for approximately $14.6 billion. Through this acquisition, Johnson & Johnson aimed to strengthen its neuroscience and central nervous system (CNS) therapeutic portfolio by incorporating new FDA-approved medicines and pipeline assets targeting psychiatric and neurodegenerative disorders, enhancing its capabilities in mental health and CNS drug development. Intra-Cellular Therapies Inc. is a US-based biopharmaceutical company that provides nervous system active pharmaceutical ingredients.

Major companies operating in the nervous system active pharmaceutical ingredients market are F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG., Thermo Fisher Scientific Inc., GSK plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Cipla Limited, Zydus Lifesciences Limited, Biocon Ltd., Siegfried Holding AG., Alkem Laboratories Ltd., Almac Group, Torrent Pharmaceuticals Ltd., Granules India Ltd., Wockhardt Ltd., Neuland Laboratories Ltd., Hetero Labs Ltd., MSN Laboratories Pvt. Ltd., and Piramal Pharma.

North America was the largest region in the nervous system active pharmaceutical ingredients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period The regions covered in the nervous system active pharmaceutical ingredients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nervous system active pharmaceutical ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nervous system active pharmaceutical ingredients market consists of sales of synthetic active pharmaceutical ingredients, biologically derived active pharmaceutical ingredients, generic active pharmaceutical ingredients, and branded active pharmaceutical ingredients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nervous System Active Pharmaceutical Ingredients Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nervous system active pharmaceutical ingredients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nervous system active pharmaceutical ingredients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nervous system active pharmaceutical ingredients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Cytokines; Vaccines; Fusion Proteins; Therapeutic Enzymes
• 2) By Expression System: Mammalian; Microbial Yeast
• 3) By Application: Diabetes; Cardiovascular Diseases; Oncology; Neurological Disorder
• 4) By End User: Pharmaceutical Companies; Biopharmaceutical Companies; Contract Development And Manufacturing Organizations; Research And Development Laboratories; Generic Drug Manufacturers
• Subsegments:
• 1) By Cytokines: Interleukin Cytokines; Interferon Cytokines; Tumor Necrosis Factor Cytokines; Growth Factor Cytokines; Chemokine Cytokines
• 2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Subunit Vaccines; Recombinant Vaccines; Conjugate Vaccines
• 3) By Fusion Proteins: Antibody Fusion Proteins; Receptor Fusion Proteins; Enzyme Fusion Proteins; Ligand Fusion Proteins; Multifunctional Fusion Proteins
• 4) By Therapeutic Enzymes: Replacement Enzymes; Digestive Enzymes; Metabolic Enzymes; Detoxifying Enzymes; Neuroprotective Enzymes
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Pfizer Inc.; Novartis AG.; Thermo Fisher Scientific Inc.; GSK plc; Eli Lilly and Company; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Ltd.; Cipla Limited; Zydus Lifesciences Limited; Biocon Ltd.; Siegfried Holding AG.; Alkem Laboratories Ltd.; Almac Group; Torrent Pharmaceuticals Ltd.; Granules India Ltd.; Wockhardt Ltd.; Neuland Laboratories Ltd.; Hetero Labs Ltd.; MSN Laboratories Pvt. Ltd.; and Piramal Pharma.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Nervous System Active Pharmaceutical Ingredients Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Nervous System Active Pharmaceutical Ingredients Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Nervous System Active Pharmaceutical Ingredients Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Nervous System Active Pharmaceutical Ingredients Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 High Potency Neurology Api Development
  • 4.2.2 Complex Cns Molecule Synthesis
  • 4.2.3 Peptide Based Neuro Apis
  • 4.2.4 Controlled Release Neuro Api Formats
  • 4.2.5 Specialized Neuro Api Cdmo Partnerships

5. Nervous System Active Pharmaceutical Ingredients Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biopharmaceutical Companies
• 5.3 Generic Drug Manufacturers
• 5.4 Contract Development And Manufacturing Organizations
• 5.5 Research And Development Laboratories

6. Nervous System Active Pharmaceutical Ingredients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nervous System Active Pharmaceutical Ingredients Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Nervous System Active Pharmaceutical Ingredients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Nervous System Active Pharmaceutical Ingredients Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Nervous System Active Pharmaceutical Ingredients Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Nervous System Active Pharmaceutical Ingredients Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nervous System Active Pharmaceutical Ingredients Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nervous System Active Pharmaceutical Ingredients Market Segmentation

• 9.1. Global Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cytokines, Vaccines, Fusion Proteins, Therapeutic Enzymes
• 9.2. Global Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Expression System, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mammalian, Microbial Yeast
• 9.3. Global Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diabetes, Cardiovascular Diseases, Oncology, Neurological Disorder
• 9.4. Global Nervous System Active Pharmaceutical Ingredients Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development And Manufacturing Organizations, Research And Development Laboratories, Generic Drug Manufacturers
• 9.5. Global Nervous System Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Cytokines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Interleukin Cytokines, Interferon Cytokines, Tumor Necrosis Factor Cytokines, Growth Factor Cytokines, Chemokine Cytokines
• 9.6. Global Nervous System Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Recombinant Vaccines, Conjugate Vaccines
• 9.7. Global Nervous System Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Fusion Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibody Fusion Proteins, Receptor Fusion Proteins, Enzyme Fusion Proteins, Ligand Fusion Proteins, Multifunctional Fusion Proteins
• 9.8. Global Nervous System Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Therapeutic Enzymes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Replacement Enzymes, Digestive Enzymes, Metabolic Enzymes, Detoxifying Enzymes, Neuroprotective Enzymes

10. Nervous System Active Pharmaceutical Ingredients Market Regional And Country Analysis

• 10.1. Global Nervous System Active Pharmaceutical Ingredients Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Nervous System Active Pharmaceutical Ingredients Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nervous System Active Pharmaceutical Ingredients Market

• 11.1. Asia-Pacific Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nervous System Active Pharmaceutical Ingredients Market

• 12.1. China Nervous System Active Pharmaceutical Ingredients Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nervous System Active Pharmaceutical Ingredients Market

• 13.1. India Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nervous System Active Pharmaceutical Ingredients Market

• 14.1. Japan Nervous System Active Pharmaceutical Ingredients Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nervous System Active Pharmaceutical Ingredients Market

• 15.1. Australia Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nervous System Active Pharmaceutical Ingredients Market

• 16.1. Indonesia Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nervous System Active Pharmaceutical Ingredients Market

• 17.1. South Korea Nervous System Active Pharmaceutical Ingredients Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nervous System Active Pharmaceutical Ingredients Market

• 18.1. Taiwan Nervous System Active Pharmaceutical Ingredients Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nervous System Active Pharmaceutical Ingredients Market

• 19.1. South East Asia Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nervous System Active Pharmaceutical Ingredients Market

• 20.1. Western Europe Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nervous System Active Pharmaceutical Ingredients Market

• 21.1. UK Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nervous System Active Pharmaceutical Ingredients Market

• 22.1. Germany Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nervous System Active Pharmaceutical Ingredients Market

• 23.1. France Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nervous System Active Pharmaceutical Ingredients Market

• 24.1. Italy Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nervous System Active Pharmaceutical Ingredients Market

• 25.1. Spain Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nervous System Active Pharmaceutical Ingredients Market

• 26.1. Eastern Europe Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nervous System Active Pharmaceutical Ingredients Market

• 27.1. Russia Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nervous System Active Pharmaceutical Ingredients Market

• 28.1. North America Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nervous System Active Pharmaceutical Ingredients Market

• 29.1. USA Nervous System Active Pharmaceutical Ingredients Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nervous System Active Pharmaceutical Ingredients Market

• 30.1. Canada Nervous System Active Pharmaceutical Ingredients Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nervous System Active Pharmaceutical Ingredients Market

• 31.1. South America Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nervous System Active Pharmaceutical Ingredients Market

• 32.1. Brazil Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nervous System Active Pharmaceutical Ingredients Market

• 33.1. Middle East Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nervous System Active Pharmaceutical Ingredients Market

• 34.1. Africa Nervous System Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Nervous System Active Pharmaceutical Ingredients Market, Segmentation By Product, Segmentation By Expression System, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nervous System Active Pharmaceutical Ingredients Market Regulatory and Investment Landscape

36. Nervous System Active Pharmaceutical Ingredients Market Competitive Landscape And Company Profiles

• 36.1. Nervous System Active Pharmaceutical Ingredients Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Nervous System Active Pharmaceutical Ingredients Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Nervous System Active Pharmaceutical Ingredients Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Novartis AG. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

37. Nervous System Active Pharmaceutical Ingredients Market Other Major And Innovative Companies

• Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Cipla Limited, Zydus Lifesciences Limited, Biocon Ltd., Siegfried Holding AG., Alkem Laboratories Ltd., Almac Group, Torrent Pharmaceuticals Ltd., Granules India Ltd., Wockhardt Ltd., Neuland Laboratories Ltd., Hetero Labs Ltd., MSN Laboratories Pvt. Ltd.

38. Global Nervous System Active Pharmaceutical Ingredients Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Nervous System Active Pharmaceutical Ingredients Market

41. Nervous System Active Pharmaceutical Ingredients Market High Potential Countries, Segments and Strategies

• 41.1 Nervous System Active Pharmaceutical Ingredients Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Nervous System Active Pharmaceutical Ingredients Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Nervous System Active Pharmaceutical Ingredients Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer